Phosphatidylserine
SupplementThe medical and community scores are closely aligned (−2 points). Clinical evidence shows moderate, consistent effects [s1, s2, s3], consistent with the positive but non-euphoric community perception [c1, c2, c3]. A limiting factor is the source issue (soy vs. bovine brain) [s14], which is also discussed within the community [c2].
Unlock full information
Dosages, side effects, studies and more — free after registration.
Register for freeRating Scales
TL;DR
Phosphatidylserine is one of the few nootropics with an FDA-recognized qualified health claim for cognitive function — evidence for memory and focus improvements in older adults and cortisol reduction during exercise is moderate but consistent. 300 mg/day split into three doses is the best-supported protocol; higher doses (>600 mg) increase the risk of sleep disturbances and headaches without clear additional benefit. Bovine PS (BC-PS) from older studies is no longer available in the EU — soy or sunflower PS are the current alternatives, though full equivalence in efficacy is not firmly established. Tolerance development with continuous use is frequently reported in the community; cycling is advisable.
Description
Phospholipid component of neuronal membranes; clinical evidence for moderate improvement of memory, concentration, and stress response (HPA axis) in older adults and children with ADHD...
Phosphatidylserine (PS) is an aminophospholipid present in all body cells but particularly concentrated in neuronal membranes – up to 15% of all phospholipids in the brain [s13]. In cerebral gray matter and the retina, PS contains over 36% docosahexaenoic acid (DHA), an omega-3 fatty acid with independent neuroprotective activity [s13]. Initially, clinical studies were conducted with PS derived from bovine brain (BC-PS); since the BSE risk emerged, dietary supplements have been predominantly manufactured from soy or sunflower lecithin (S-PS) [s9, s14]. Soy-PS contains less DHA and may demonstrate smaller cognitive effects than BC-PS in comparative studies, although direct head-to-head RCTs are lacking [s14]. Clinical studies in older adults with age-related memory decline demonstrate moderate improvements in memory, attention, and processing speed [s1, s2]. A meta-analysis (2022) shows significant effects on cognitive function in aging [s1]. In children with ADHD, systematic reviews indicate a reduction in inattention symptoms, though evidence quality is low [s3, s4]. PS supplementation at 400 mg/d (as a PAS complex) normalizes HPA axis hyperreactivity in chronically stressed men [s5]. The substance is available over the counter in Germany as a dietary supplement (NEM), without authorization but subject to notification requirements [s11].
Legal Status (DE)
Marketable in Germany as an over-the-counter dietary supplement (NEM); notification to BVL required. EFSA did not positively evaluate health claims related to cognition and memory (Opinion 2010) [s10, s11]. The FDA has issued a qualified health claim for phosphatidylserine derived from soy, fish, and sunflower regarding cognitive function and reduction of dementia risk [s12].
Mechanism of Action
Phosphatidylserine is a structural component of the inner leaflet of neuronal cell membranes and contributes to membrane fluidity and signal transduction [s13]. Cognitive and endocrine effects are explained through the following mechanisms: 1. Membrane stabilization and neurotransmitter release: PS supports the function of membrane-bound enzymes and ion channels, facilitating the release of acetylcholine, dopamine, and serotonin [s13, s15]. 2. HPA axis modulation: PS inhibits excessive cortisol secretion following acute stress. 800 mg BC-PS reduced the cortisol response to intense exercise by approximately 30% [s6]; a PAS complex (400 mg/d) significantly normalized HPA axis hyperreactivity in chronically stressed men [s5]. 3. Neuroprotection: PS inhibits in vitro the production of proinflammatory cytokines (TNF-α, NO) induced by amyloid-β and IFN-γ in microglia and reduces reactive oxygen species (ROS) [s9]. 4. Apoptosis signal: PS is translocated to the outer leaflet of the cell membrane during apoptosis, signaling macrophages for phagocytosis. This mechanism is relevant to systemic activity [s13]. 5. DHA carrier function: Soy-PS contains less DHA than BC-PS; a portion of the cognition-enhancing effect of BC-PS has been attributed to its bound DHA [s14].
Dosing
Kognition und Gedächtnis (ältere Erwachsene)
- Dose
- 300 mg daily, divided into 3 × 100 mg
- Frequency
- 3× täglich zu den Mahlzeiten
- Route
- oral
- Duration
- 8–12 Wochen, dann Pause oder fortlaufend
- Timing
- With meals for better tolerability
- With food
- empfohlen
Stressreduktion / HPA-Achse
- Dose
- 400 mg daily (as PAS complex)
- Frequency
- 1–2× täglich
- Route
- oral
- Duration
- 6–8 Wochen
- Timing
- With food
- With food
- empfohlen
ADHS bei Kindern (ergänzend)
- Dose
- 200 mg daily
- Frequency
- 2× täglich à 100 mg
- Route
- oral
- Duration
- 2 Monate
- Timing
- With food, morning and midday
- With food
- empfohlen
Cortisolreduktion bei Sport
- Dose
- 600–800 mg daily
- Frequency
- Aufgeteilt auf 2–3 Dosen
- Route
- oral
- Duration
- 10–14 Tage
- Timing
- Before or after training
- With food
- empfohlen
Doses above 300 mg/d increase the risk of gastrointestinal complaints and sleep disturbances [s7]. Sleep disturbances and headaches have been reported at doses above 600 mg/d [s8]. EFSA cites 300–400 mg/d as the typical study dose; no official maximum daily amount has been established for Germany [s10, s11].
Soy-PS is the market-dominant form since the BSE risk emerged. Sunflower-PS is also available. BC-PS (bovine brain) is no longer marketable in the EU. Studies conducted with BC-PS are not directly transferable to S-PS [s14].
Side Effects
| Side Effect | Frequency | Severity |
|---|---|---|
| bleeding_risk_note_de | selten | leicht |
| bleeding_risk_source_ids | selten | leicht |
Contraindications
Theoretical anticoagulant effect of PS; combined with anticoagulants, increased bleeding risk possible [s16, s8].
Commercially available preparations are soy-based PS; allergic reactions possible [s8].
Theoretically additive cholinergic effects due to increased acetylcholine synthesis; abnormal acetylcholine levels possible [s15].
Insufficient safety data for pregnant or breastfeeding women; use only after medical consultation [s7].
Interactions
Synergistic
No peer-reviewed RCT on the direct combination of PS + ashwagandha found. Both substances independently reduce cortisol via HPA axis modulation (PS: pituitary level; ashwagandha: withanolides → adrenocortical level), making an additive effect mechanistically plausible. The claim of 50% superior combined cortisol reduction originates from non-scientific sources...
No direct RCT on the PS + Bacopa combination available. s19 (Zanotta 2014, PMID 24523587) is an open-label multicenter study using a multi-combination preparation (Bacopa + PS + astaxanthin + Vit. E, n=104, MCI); synergistic effect not isolable. s20 (PMC12938011, 2025) is an in vitro study demonstrating synergistic neuroprotective effects of Bacopa + PS + choline. Overall evidence: preliminary/pr...
No peer-reviewed RCT or clinical study on the PS + ALCAR combination found. The claimed synergistic effect on cholinergic cognition and mitochondrial membrane function is mechanistically plausible (ALCAR: mitochondrial energetics + ACh precursor; PS: membrane fluidity + neurotransmitter release), but not clinically established. Classification: mechanistic/theoretical.
No peer-reviewed evidence for a PS + Panax ginseng combination regarding cortisol normalization or stress resilience found. Both substances independently modulate the HPA stress response; a synergistic interaction is speculative. Classification: theoretical.
No peer-reviewed evidence for a PS + Alpha-GPC combination on cholinergic cognition found. Mechanistically plausible: Alpha-GPC supplies choline for ACh synthesis; PS stabilizes neuronal membranes and promotes neurotransmitter exocytosis. Direct clinical evidence is lacking. Classification: mechanistic/theoretical.
Hellhammer et al. 2004 [s21] investigated a soy lecithin-phosphatidic acid-PS combination (PAS) under mental stress and found significant attenuation of the ACTH and cortisol response. This is the primary clinical reference behind the synergy claim; the ZRT blog [s17] is merely a secondary retelling and should not be used as a sole source.
Community Evidence
Top reported benefits
- Improved concentration and focus (reported on r/Nootropics, r/Supplements)
- Anxiolytic effect / stress reduction
- Clearer thinking and reduced brain fog
- Improved learning and memory performance
- Better sleep at lower doses (100–200 mg)
Top reported issues
- No noticeable effect in a subset of users
- Tolerance development with prolonged use; cycling recommended
- Sleep disturbances at doses above 300 mg taken in the evening
- Uncertainty about quality differences between PS sources
Several community members report that effects are consistently reproducible only with high-quality products (e.g., Nootropics Depot) [c2]. Discussion regarding the superiority of BC-PS vs. S-PS is present in the community, though BC-PS is unavailable in Europe [c2, c4]. Tolerance development after several weeks of daily use is frequently discussed [c3].
Scientific Sources
- Effect of phosphatidylserine on cognitive function in the elderly: A systematic review and meta-analysis
Kang EY, Cui F, Kim HK, Lim GY, Jung HJ (2022). Korean Journal of Food Science and TechnologyB - Effect of phosphatidylserine on cognitive function in the elderly: A systematic review and meta-analysis
Kang EY, et al. (2022). Korean Journal of Food Science and TechnologyALink - Scientific Opinion on the substantiation of health claims related to phosphatidyl serine (ID 552, 711, 734, 1632, 1927) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
EFSA Panel on Dietetic Products, Nutrition and Allergies (2010). EFSA JournalADOI - Fragen und Antworten zu Nahrungsergänzungsmitteln
Bundesinstitut für Risikobewertung (BfR) (2022). BfRALink - Qualified Health Claims: Letters of Enforcement Discretion – Phosphatidylserine and Cognitive Function and Dementia
U.S. Food and Drug Administration (2004). FDA CFSANALink - Phosphatidylserin – Suppleminds Wiki
Suppleminds Redaktion (2023). SupplemindsBLink - Phosphatidylserine: Benefits, Forms, Dosing, and Side Effects
Stanfield B (2023). drstanfield.comBLink - Phosphatidylserin: Vorteile, Dosierung, Kontraindikationen
Darwin Nutrition Redaktion (2023). Darwin NutritionBLink - Anticoagulant effect of phosphatidylserine
Zubairov DM, Andrushko IA, Zubairova LD (1981). BiokhimiiaCPMID:7314577 - Phosphatidylserine – Protection from the Effects of Chronic Stress
ZRT Laboratory Editorial Team (2022). ZRT Laboratory BlogBLink - Effects of a food supplement containing phosphatidylserine on cognitive function in Chinese older adults with mild cognitive impairment: A randomized double-blind, placebo-controlled trial
Li Z, et al. (2024). Journal of Affective DisordersAPMID:39317299DOI - Effects of soy lecithin phosphatidic acid and phosphatidylserine complex (PAS) on the endocrine and psychological responses to mental stress
Hellhammer J, Fries E, Buss C, Engert V, Tuch A, Rutenberg D, Hellhammer D (2004). StressBDOI - Phosphatidylserine for the Treatment of Pediatric Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis
Bruton A, Nauman J, Hanes D, et al. (2021). Journal of Alternative and Complementary MedicineAPMID:33539192DOI - The effect of phosphatidylserine administration on memory and symptoms of attention-deficit hyperactivity disorder: a randomised, double-blind, placebo-controlled clinical trial
Hirayama S, Terasawa K, Rabeler R, et al. (2014). Journal of Human Nutrition and DieteticsAPMID:23495677DOI - A soy-based phosphatidylserine/phosphatidic acid complex (PAS) normalizes the stress reactivity of hypothalamus-pituitary-adrenal-axis in chronically stressed male subjects: a randomized, placebo-controlled study
Hellhammer J, Vogt D, Franz N, et al. (2014). Lipids in Health and DiseaseAPMID:25081826DOI - The effects of phosphatidylserine on endocrine response to moderate intensity exercise
Starks MA, Starks SL, Kingsley M, et al. (2008). Journal of the International Society of Sports NutritionALink - Phosphatidylserine: Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews
WebMD Editorial Team (2024). WebMD Vitamins & SupplementsBLink - Phosphatidyl-Serin – Nebenwirkungen
DocMedicus Vitalstofflexikon Redaktion (2023). DocMedicus VitalstofflexikonBLink - Phosphatidylserine and the human brain
Kidd PM (2015). NutritionBPMID:25933483DOI
Community Sources
Storage
Unopened
Store in a dry, cool place (15–25 °C), protected from light and moisture.
Opened
Seal container tightly after use; protect powder and capsules from moisture.
Notes
PS-containing products may oxidize upon exposure to light and heat; refrigerated storage after opening is recommended for sensitive formulations.